Prof. Michael H. Glickman was awarded an ISF Breakthrough Research Grant (BRG) in the amount of NIS 4 million for the groundbreaking study on the role of ubiquitin in Alzheimer’s pathology.
Prof. Michael H. Glickman was awarded an ISF Breakthrough Research Grant (BRG) in the amount of NIS 4 million for the groundbreaking study on the role of ubiquitin in Alzheimer’s pathology.